Global Infectious Diseases Diagnostics Market Size Study, by Product & Service (Assays, Kits, Reagents, Instruments, Services & Software) by Technology (Immunodiagnostics, Clinic Microbiology, DNA Microarray) by Disease Type (Tuberculosis, HAIS, HIV, Hepatitis) by End Use (Hospital, Physician Offices, Others) by Regional Forecasts 2017-2025
-
Product Code:
RP-ID-10013261 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Pages:
180 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-14
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Infectious Diseases Diagnostics Market valued approximately USD 14 billion in 2016 is anticipated to grow with a healthy growth rate of more than 6 % over the forecast period 2017-2025. Growing prevalence of infectious diseases across the globe, increasing funding for research for infectious disease diagnostics and the change in focus from centralized laboratories to decentralized point-of-care testing. Infectious disease diagnostics are several techniques used by professionals to diagnose and detect pathogens in human samples such as throat swab, urine, serum, blood, and stool.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product & Service:
 Assays, Kits, Reagents
 Instruments
 Services & Software
By Technology:
 Immunodiagnostics
 Clinic Microbiology
 Polymerase Chain Reaction (PCR)
 Isothermal Nucleic Acid Amplification Technology (INAAT)
 DNA Sequencing & Next-Generation Sequencing
 DNA Microarray
 Other Technologies
By Diseases Type:
 Hepatitis
o Hepatitis Diagnostics Market
 Human Immunodeficiency Virus (HIV)
 Chlamydia Trachomatis Genital Infection & Gonorrhea
 Hospital-Acquired Infection (HAIS)
 Tuberculosis
o Tuberculosis Diagnostic Market
 Influenza
o Influenza Diagnostics Market
 Other Infectious Diseases
By End-Use:
 Hospitals/Clinical Laboratories
 Reference Laboratories
 Physician Offices
 Academic/Research Institutes
 Others
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
 Asia Pacific
o China
o India
o Japan
 Latin America
o Brazil
o Mexico
 Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2015
Base year - 2016
Forecast period - 2017 to 2025
Some of the key manufacturers involved in the market Abbott Laboratories, Becton, Dickinson & Company, Danaher Corporation, Bio-Rad Laboratories, Diasorin, Luminex, Meridian Bioscience, Quidel, Roche Diagnostics, Siemens AG. Acquisitions and effective mergers are some of the strategies adopted by the key manufacturers. New product launches and continuous technological innovations are the key strategies adopted by the major players.
Target Audience of the Global Infectious Diseases Diagnostics Market in Market Study:
 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
Please enter your personal details below
Bio-Rad Laboratories
Danaher Corporation
Diasorin
Luminex
Meridian Bioscience
Quidel
Roche Diagnostics
Siemens AG